HEIGHTS CAPITAL MANAGEMENT, INC
Position in TSHA — Taysha Gene Therapies, Inc.
CIK 1081698
SAN FRANCISCO, CA
Position in TSHA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,215,000
New position
Shares Held
1,500,000
first reported quarter
Ownership
0.460%
of shares outstanding
% of Portfolio
2.95%
of 13F equity value
Holder Rank
#38
of 208 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026HEIGHTS CAPITAL MANAGEMENT, INC holds $34,693,958 across 12 Biotechnology names. TSHA ranks #2 (29.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MGTX |
MeiraGTx Holdings plc
|
850,000 | $11,483,500 | |
| 2 | TSHA |
Taysha Gene Therapies, Inc.
This page
|
1,500,000 | $10,215,000 | |
| 3 | PRQR |
ProQR Therapeutics N.V.
|
2,762,430 | $5,138,119 | |
| 4 | CABA |
Cabaletta Bio, Inc.
|
755,626 | $2,349,996 | |
| 5 | MLTX |
MoonLake Immunotherapeutics
|
100,000 | $1,947,000 | |
| 6 | CALC |
CalciMedica, Inc.
|
1,556,081 | $1,602,763 | |
| 7 | QURE |
uniQure N.V.
|
25,000 | $1,151,500 | |
| 8 | RANI |
Rani Therapeutics Holdings, Inc.
|
934,580 | $710,280 |
All Filings in TSHA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,215,000 | 1,500,000 | Shares | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||